COPD Foundation links arms with ENA on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu

Fierce Pharma

28 February 2022
COPD Foundation links arms with ENA on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu

View article